Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
PLoS One ; 15(8): e0236727, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32750068

RESUMO

Low-power laser irradiation (LPLI) is clinically used to modulate inflammation, proliferation and apoptosis. However, its molecular mechanisms are still not fully understood. This study aimed to describe the effects of LPLI upon inflammatory, apoptotic and proliferation markers in submandibular salivary glands (SMGs) in an experimental model of chronic disorder, 24h after one time irradiation. Diabetes was induced in rats by the injection of streptozotocin. After 29 days, these animals were treated with LPLI in the SMG area, and euthanized 24h after this irradiation. Treatment with LPLI significantly decreased diabetes-induced high mobility group box 1 (HMGB1) and tumor necrosis factor alpha (TNF-α) expression, while enhancing the activation of the transcriptional factor cAMP response element binding (CREB) protein. LPLI also reduced the expression of bax, a mitochondrial apoptotic marker, favoring the cell survival. These findings suggest that LPLI can hamper the state of chronic inflammation and favor homeostasis in diabetic rats SMGs.


Assuntos
Diabetes Mellitus Experimental/radioterapia , Terapia com Luz de Baixa Intensidade , Transdução de Sinais/efeitos da radiação , Glândula Submandibular/efeitos da radiação , Animais , Apoptose , AMP Cíclico/metabolismo , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/metabolismo , Feminino , Proteína HMGB1/genética , Proteína HMGB1/metabolismo , Proteínas Quinases Ativadas por Mitógeno/metabolismo , NF-kappa B/metabolismo , Fosforilação , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Fator de Necrose Tumoral alfa/metabolismo
2.
Ear Nose Throat J ; 98(6): E64-E69, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31032661

RESUMO

Radiotherapy is a method of treatment used on malignant head and neck tumors; however, it may lead to adverse effects by influencing other tissues because its effects are not specific to tumor tissues. These adverse effects limit the effectiveness of the treatment and sometimes lead to termination of the treatment. This study aims to histopathologically and biochemically investigate the protective effect of whortleberry against the cellular degeneration and oxidative stress that take place in salivary glands due to radiotherapy. The rats were divided into 6 groups. One group was given radiotherapy only, one group was given radiotherapy and 100 mg/kg of whortleberry, and one group was given radiotherapy and 200 mg/kg of whortleberry. The remaining 3 groups were designated as whortleberry, sham, and control groups. At the end of the study, samples collected were histopathologically and biochemically analyzed. In the group given radiotherapy only, acinar areas were reduced histopathologically, whereas ductal areas increased (P < .01). Oxidative stress increased only in the group given radiotherapy, whereas the oxidative stress levels in the other groups were close to those in the control groups. In conclusion, whortleberry reduces cellular degeneration and oxidative stress that take place in salivary glands due to radiotherapy.


Assuntos
Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/efeitos da radiação , Extratos Vegetais/farmacologia , Glândula Submandibular/efeitos dos fármacos , Glândula Submandibular/efeitos da radiação , Vaccinium myrtillus , Animais , Masculino , Pescoço , Radiação Ionizante , Radioterapia Conformacional , Ratos , Glândulas Salivares/efeitos dos fármacos , Glândulas Salivares/metabolismo , Glândulas Salivares/efeitos da radiação , Glândula Submandibular/metabolismo
3.
Medicine (Baltimore) ; 97(17): e0538, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29703031

RESUMO

BACKGROUND: Episodes of malnutrition in early childhood can produces alterations in the salivary glands. The investigation of mechanisms that can reduce the impact of malnutrition on the defenses of the organism is of the utmost important and interest to public health. The aim of this study is to evaluate the effect of low-level laser on the saliva of children aged 1 to 5 years with energy-protein malnutrition. METHODS: Mandatory inclusion criteria are diagnosis of malnutrition. The sample will consist of 50 men and women malnourished children aged 12 to 71 months. Saliva will be collected and the volume of saliva will be measured and the salivary flow rate will be determined (mL/min). Concentrations of salivary IgA in all samples will be measured using a commercial Enzyme-Linked Immunosorbent Assay (ELISA) kit. Low-level laser (laser diode) will be administered in the region of the parotid glands bilaterally as well as in the regions of the submandibular and sublingual glands. DISCUSSION: This study will be the first that investigate the effects of local laser therapy on the salivary glands of malnourished children. TRIAL REGISTRATION: Clinical.trials.gov as NCT03355313, first received in 21 November 2017.


Assuntos
Transtornos da Nutrição Infantil/complicações , Lasers Semicondutores/uso terapêutico , Terapia com Luz de Baixa Intensidade/métodos , Desnutrição Proteico-Calórica/complicações , Saliva/efeitos da radiação , Glândulas Salivares/efeitos da radiação , Pré-Escolar , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imunoglobulina A Secretora/análise , Lactente , Masculino , Estado Nutricional , Glândula Parótida/efeitos da radiação , Saliva/imunologia , Saliva/metabolismo , Glândula Sublingual/efeitos da radiação , Glândula Submandibular/efeitos da radiação , Resultado do Tratamento
4.
PLoS One ; 12(1): e0169443, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28099448

RESUMO

Diabetes can lead to dysfunction of the secretory capacity in salivary glands. Activation of the receptor for advanced glycation end products (RAGE) and its ligands has been suggested to participate in chronic disorders such as diabetes and its complications. In this study, the expression of RAGE, high mobility group box 1 (HMGB1) and advanced glycation end products (AGE), as well as the effects of low-power laser irradiation (LPLI) in salivary glands of diabetic rats were evaluated, and the mechanisms involved were characterized. The expression of RAGE and HMGB1 at the protein and mRNA levels was observed in submandibular glands (SMGs) of streptozotocin-induced diabetic rats. A diode laser was applied at 660 nm, 70 mW, 20 J/cm2, 0.56 J/point, with a spot area of 0.028 cm2 and its in vivo effects and the pathways involved were evaluated. Immunohistochemistry and western blotting analysis were performed for inflammatory and apoptosis markers. Diabetes up-regulates HMGB1/AGE/RAGE axis gene expression in SMGs that is associated with activation of the nuclear factor kappa B (NF-κB) pathway. Interestingly, LPLI suppresses NF-κB activation induced by inflammation. LPLI also reduces diabetes-induced apoptosis. That effect was accompanied by decreased levels of Bax, and cleaved caspase 3, which were up-regulated in diabetes. Taken together, our data suggest that LPLI reduces diabetes-induced inflammation by reducing the induction of HMGB1, ultimately leading to inhibition of apoptosis in submandibular glands of diabetic rats.


Assuntos
Diabetes Mellitus Experimental/complicações , Sialadenite/radioterapia , Glândula Submandibular/efeitos da radiação , Animais , Apoptose/efeitos da radiação , Diabetes Mellitus Experimental/patologia , Feminino , Produtos Finais de Glicação Avançada/metabolismo , Proteína HMGB1/metabolismo , Terapia com Luz de Baixa Intensidade , Ratos , Ratos Wistar , Receptor para Produtos Finais de Glicação Avançada/metabolismo , Sialadenite/metabolismo , Sialadenite/patologia , Glândula Submandibular/patologia
5.
Endocrinol Nutr ; 62(10): 493-8, 2015 Dec.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-26459118

RESUMO

OBJECTIVES: To assess the incidence of 131I-induced sialadenitis (SD) in patients with differentiated thyroid cancer (DTC), to analyze clinical and other factors related to metabolic radiotherapy that may predict the lack of response to conventional medical therapy (CMT), and to determine the effectiveness of intraductal steroid instillation in patients failing CMT. MATERIAL AND METHODS: Fifty-two patients with DTC, 45 females (86.5%) and 7 males (13.5%) with a mean age of 44.21±13.3 years (r=17-74) who received ablation therapy with 131I after total thyroidectomy. Patients with diseases and/or medication causing xerostomia were excluded. Patients underwent salivary gland scintigraphy with 99Tc (10mCi). RESULTS: Eighteen patients (34.62%) had SD and received antibiotics, antispasmodics, and oral steroids for 15 days. They were divided into two groups: responders to medical therapy (n=12, age 44.3±14.4 years, 2 men [17%], 10 women [83%], cumulative dose 225±167.1 mCi) and non-responders to medical treatment, who underwent steroid instillation into the Stensen's duct (n=6 [33%], 2 men [33%], 4 women [67%], age 50±13.8 years, cumulative dose 138.3±61.7 mCi). Scintigraphy showed damage to the parotid and submaxillary glands. CONCLUSION: Incidence of 131I-induced sialadenitis was similar to that reported by other authors. Age, mean cumulative dose of 131I, and involvement of parotid and submaxillary glands did not condition response to CMT; however, male sex was a conditioning factor. Symptom persistence for more than 15 days makes instillation into the Stensen's duct advisable. This is an effective and safe method to avoid surgical excision of salivary glands.


Assuntos
Corticosteroides/uso terapêutico , Antibacterianos/uso terapêutico , Radioisótopos do Iodo/efeitos adversos , Parassimpatolíticos/uso terapêutico , Radioterapia Adjuvante/efeitos adversos , Sialadenite/tratamento farmacológico , Adolescente , Corticosteroides/administração & dosagem , Adulto , Idoso , Terapia Combinada , Quimioterapia Combinada , Feminino , Humanos , Instilação de Medicamentos , Radioisótopos do Iodo/uso terapêutico , Masculino , Pessoa de Meia-Idade , Glândula Parótida/patologia , Glândula Parótida/efeitos da radiação , Ductos Salivares , Sialadenite/diagnóstico por imagem , Sialadenite/epidemiologia , Sialadenite/prevenção & controle , Glândula Submandibular/patologia , Glândula Submandibular/efeitos da radiação , Neoplasias da Glândula Tireoide/radioterapia , Neoplasias da Glândula Tireoide/cirurgia , Tireoidectomia , Adulto Jovem
6.
Lasers Med Sci ; 30(4): 1275-80, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25722066

RESUMO

The aim of this study was to analyze the influence of laser photobiomodulation in salivary flow, weight, and histomorphometry of the submandibular glands of hypothyroid rats. Fifty-six male Wistar albino rats were divided in euthyroid group and hypothyroid group, treated with propylthiouracil (PTU) to induce hypothyroidism. Each group was divided into control (without laser) and laser groups (GaAlAs): λ660 nm (40 mW), λ780 nm (40 mW), and λ780 nm (70 mW). The laser application on the submandibular gland occurred after 2 weeks of PTU treatment and repeatedly during 2 weeks every 48 h. The rats were anesthetized, tracheostomized, and the evaluation of the salivary flow rate (µL/min/100 g body weight) was made by the weight of the saliva collected for 15 min from the first drop. After the animals' death, the glands were dissected and processed for histological analysis. There was an evident reduction of the salivary flow of hypothyroid rats in all groups in comparison to euthyroid group (Mann-Whitney test, p < 0.05). No significant difference was found in the salivary flow of rats that received laser photobiomodulation compared with their control groups. Histological analysis revealed a decrease in the parenchyma of the salivary glands of hypothyroid rats, but the laser was not able to reverse this process. Hypothyroid rats irradiated or not with laser showed acini and acinar cells with significantly smaller areas than euthyroid groups. The laser photobiomodulation protocol used was not able to change salivary flow or reverse the acinar atrophy process in the submandibular glands of hypothyroid rats.


Assuntos
Hipotireoidismo/radioterapia , Lasers Semicondutores/uso terapêutico , Terapia com Luz de Baixa Intensidade , Saliva/fisiologia , Glândula Submandibular/efeitos da radiação , Animais , Masculino , Tamanho do Órgão/efeitos da radiação , Ratos , Ratos Wistar , Glândula Submandibular/patologia
7.
Nutr Cancer ; 66(3): 400-7, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24617451

RESUMO

Numerous studies' attempts to improve radiation-induced oral mucositis have not produced a qualified treatment yet. Our aim was to investigate the effectiveness of Korean red ginseng (KRG) on radiation-induced damage in an in vivo rat model. After 20 Gy of irradiation, rats were divided randomly into the following 4 groups: control, KRG only, radiotherapy (RT) only, and RT + KRG group. The rats were monitored in terms of survival rate, activity, mucositis grade, oral intake, and body weight. The tongue, buccal mucosa, and submandibular gland (SMG) were harvested, and the weight of the SMG was analyzed. The samples then underwent hematoxylin and eosin, TUNEL, and immunohistochemical staining. Radiation-induced severe oral mucositis and SMG injury led to poor oral intake and delayed healing, resulting in the death of some rats. We found that survival rate, oral intake, and body weight increased. Moreover, rats treated with KRG showed less severe mucositis and decreased histologic changes of the oral mucosa and SMG. Furthermore, we showed that the protective effects of KRG were caused by inhibition of the apoptotic signal transduction pathway linked to caspase-3. In conclusion, KRG protects the oral mucosa and SMG from radiation-induced damage by inhibiting caspase-mediated apoptosis in rats.


Assuntos
Panax/química , Extratos Vegetais/farmacologia , Lesões por Radiação/prevenção & controle , Protetores contra Radiação/farmacologia , Estomatite/prevenção & controle , Animais , Anorexia/etiologia , Apoptose/efeitos dos fármacos , Apoptose/efeitos da radiação , Peso Corporal/efeitos dos fármacos , Caspases/metabolismo , Masculino , Lesões por Radiação/mortalidade , Ratos Sprague-Dawley , Estomatite/etiologia , Estomatite/mortalidade , Glândula Submandibular/efeitos dos fármacos , Glândula Submandibular/patologia , Glândula Submandibular/efeitos da radiação , Taxa de Sobrevida
8.
Lasers Med Sci ; 28(3): 911-8, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-22869159

RESUMO

The aim of the present study was to analyze the effect of low-power laser irradiation in the antioxidant enzymatic system of submandibular (SMG) and parotid (PG) salivary glands of streptozotocin-induced diabetic rats. The animals were randomly divided into six groups: three diabetic groups (D0, D5, and D20) and three non-diabetic groups (C0, C5, and C20), according to laser dose received (0, 5, and 20 J/cm(2), respectively). Areas of approximately 1 cm(2) were demarcated in the salivary glands (each parotid and both submandibular glands) and after irradiated according to Simões et.al. (Lasers Med Sci 24:202-208, 2009). A diode laser (660 nm/100 mW) was used, with laser beam spot of 0.0177 cm(2). The group treated with 5 J/cm(2) laser dose was subjected to irradiation for 1 min and 4 s (total irradiation time) and the group treated with 20 J/cm(2) laser dose was subjected to irradiation for 4 min and 16 s. Twenty-four hours after irradiation the animals were euthanized and the salivary glands were removed for biochemical analysis. The total antioxidant values (TA), the activity of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase enzymes were determined. SOD and CAT activities, as well as TA were higher in SMG of irradiated diabetic rats. However, in SMG of non-diabetic rats, laser irradiation decreased TA values and led to an increase in the CAT activity. In addition, there was a decrease in the activity of CAT in PG of diabetic and non-diabetic animals after laser irradiation. According to the results of the present study, low-power laser irradiation can affect the enzymatic antioxidant system of salivary glands of streptozotocin-induced diabetic rats.


Assuntos
Antioxidantes/metabolismo , Diabetes Mellitus Experimental/enzimologia , Diabetes Mellitus Experimental/radioterapia , Terapia com Luz de Baixa Intensidade , Animais , Glicemia/metabolismo , Catalase/metabolismo , Diabetes Mellitus Experimental/sangue , Feminino , Glutationa Peroxidase/metabolismo , Glândula Parótida/enzimologia , Glândula Parótida/efeitos da radiação , Ratos , Ratos Wistar , Glândula Submandibular/enzimologia , Glândula Submandibular/efeitos da radiação , Superóxido Dismutase/metabolismo
9.
J Radiat Res ; 52(5): 557-67, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21952314

RESUMO

In this study we first evaluated the general radioprotective efficacy of Se, Zn and Mn (4 µg/ml each) plus Lachesis muta venom (4 ng/ml) combination (O-LM) by determining survival on rats irradiated with lethal doses of gamma-rays. The aim of the second part of the study was to investigate the O-LM ability to prevent ionizing radiation-induced damage on small intestine, bone marrow and submandibular glands. Hence, histological characteristics and functional studies, together with proliferation and apoptotic marker levels on whole body irradiated rats with a 5 Gy dose were evaluated. Results show that all animals of the untreated group died after whole body irradiation with 8 and 10 Gy while 60 day-survival was more than 80% and 40% in O-LM-treated animals, respectively. Histopathological examinations revealed a high degree of small intestine and submandibular gland radioprotection 3 days post-irradiation. O-LM inhibited histological damage on small intestine, restoring the radiation-induced reduction in villous height and crypt number. O-LM prevented radiation-induced loss of salivary gland function and morphological alterations. These effects were associated to a complete inhibition of radiation-induced apoptosis. Furthermore, studies performed 30 days post-irradiation revealed that O-LM significantly improved bone marrow repopulation, increasing all medullar progenies to the extent of the non-irradiated animals, and completely prevented permanent submandibular gland alterations. Based on the present results and taking into account that O-LM is being safely administered in phase I clinical trial as an immunomodulator, we conclude that O-LM is a non-toxic promising approach to achieve radioprotection for patients undergoing radiotherapy.


Assuntos
Protetores contra Radiação/farmacologia , Animais , Apoptose/efeitos dos fármacos , Apoptose/efeitos da radiação , Medula Óssea/efeitos dos fármacos , Medula Óssea/lesões , Medula Óssea/efeitos da radiação , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/efeitos da radiação , Venenos de Crotalídeos/administração & dosagem , Venenos de Crotalídeos/farmacologia , Raios gama/efeitos adversos , Humanos , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/lesões , Intestino Delgado/efeitos da radiação , Masculino , Manganês/administração & dosagem , Manganês/farmacologia , Lesões Experimentais por Radiação/patologia , Lesões Experimentais por Radiação/prevenção & controle , Protetores contra Radiação/administração & dosagem , Ratos , Ratos Sprague-Dawley , Selênio/administração & dosagem , Selênio/farmacologia , Glândula Submandibular/efeitos dos fármacos , Glândula Submandibular/lesões , Glândula Submandibular/efeitos da radiação , Zinco/administração & dosagem , Zinco/farmacologia
10.
Arch Oral Biol ; 56(8): 738-43, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21292239

RESUMO

AIM: To study the protective effect of tea polyphenols (TPs) on submandibular glands affected by radiation injury. METHODS: Sixty rats were randomly divided into radiation group (R-group, N = 30) and TP-pre-treated-radiation group (TPR-group, N = 30). The rats were intragastrically administered with TP or normal sodium from 14 days before radiation, continuously daily, until the experiment. All the rats in both groups were irradiated with a single exposure dose of 15 Gy gamma rays that were delivered to the head and neck areas. Ten rats of each group were anatomised on the 3rd, 6th and 30th day after irradiation, respectively. The submandibular glands of the rats were removed for the study. The morphologic changes of the submandibular glands were observed by transmission electron microscopy (TEM). The terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP)-biotin nick-end labelling (TUNEL) method was used to detect apoptosis of the submandibular glands' cells. RESULTS: Electron microscope observation of the submandibular glands showed that the lesions of the TPR-group were mild. Change in apoptosis of the cells was not obvious compared with the R-group. The cell apotosis was typical after irradiation in the R-group. Apoptosis index that was detected in the cells of submandibular glands of the TPR-group was statistically significantly decreased compared with the R-group (P < 0.01) on the 3rd, 6th and 30th day after irradiation. CONCLUSION: TP could protect submandibular glands from radiation injuries, and the protection mechanism may be realised by anti-apoptosis.


Assuntos
Extratos Vegetais/uso terapêutico , Polifenóis/uso terapêutico , Lesões Experimentais por Radiação/prevenção & controle , Protetores contra Radiação/uso terapêutico , Glândula Submandibular/efeitos da radiação , Chá , Animais , Apoptose/efeitos dos fármacos , Apoptose/efeitos da radiação , Atrofia , Morte Celular/efeitos dos fármacos , Morte Celular/efeitos da radiação , Degranulação Celular/efeitos dos fármacos , Degranulação Celular/efeitos da radiação , Núcleo Celular/efeitos dos fármacos , Núcleo Celular/efeitos da radiação , Espaço Extracelular/efeitos dos fármacos , Espaço Extracelular/efeitos da radiação , Feminino , Raios gama , Marcação In Situ das Extremidades Cortadas , Microscopia Eletrônica de Transmissão , Organelas/efeitos dos fármacos , Organelas/efeitos da radiação , Doses de Radiação , Lesões Experimentais por Radiação/patologia , Distribuição Aleatória , Ratos , Ratos Wistar , Glândula Submandibular/efeitos dos fármacos , Glândula Submandibular/patologia , Fatores de Tempo
11.
Clin Oral Investig ; 12(1): 25-30, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17624559

RESUMO

This study aims to investigate whether infrared diode low-level laser therapy (LLLT) increased salivary flow rate and altered pH value, protein concentration, and peroxidase and amylase activities in saliva of rats. Wistar rats were used and divided into three groups. Experimental groups (A and B) had their parotid, submandibular and sublingual glands submitted to diode laser, 808-nm wavelength, on two consecutive days. The dose results were 4 and 8 J/cm(2), respectively. A red guide light was used to visualize the irradiated area. Group C was irradiated only with red pilot beam and served as control. The saliva samples were collected after each irradiation step (first and second collection days) and 1 week after the first irradiation (seventh day). Statistical analysis was performed, and differences were observed according to different days of salivary collection. The results showed that salivary flow rate for groups A and B was higher on the seventh day if it is compared to data obtained for the first day (p < 0.05). LLLT applications on salivary glands are a therapy procedure that requires further studies.


Assuntos
Lasers Semicondutores/uso terapêutico , Terapia com Luz de Baixa Intensidade/métodos , Saliva/efeitos da radiação , Glândulas Salivares/efeitos da radiação , Amilases/efeitos da radiação , Animais , Concentração de Íons de Hidrogênio , Masculino , Glândula Parótida/metabolismo , Glândula Parótida/efeitos da radiação , Peroxidase/efeitos da radiação , Doses de Radiação , Ratos , Ratos Wistar , Saliva/metabolismo , Glândulas Salivares/metabolismo , Proteínas e Peptídeos Salivares/efeitos da radiação , Taxa Secretória/efeitos da radiação , Espectrofotometria , Glândula Sublingual/metabolismo , Glândula Sublingual/efeitos da radiação , Glândula Submandibular/metabolismo , Glândula Submandibular/efeitos da radiação
12.
Rev Med Suisse ; 3(127): 2225-9, 2007 Oct 03.
Artigo em Francês | MEDLINE | ID: mdl-17970157

RESUMO

Most of head and neck cancer patients will undergo radiotherapy. Xerostomia is probably its most frequent side effect. Subjective and objective criteria allow evaluating and grading xerostomia. New radiotherapy techniques and use of cytoprotectants can help to preserve salivary gland function. Parasym-pathicomimetics and saliva substitutes reduce symptoms. Strict mouth cleaning and fluoride's use prevent teeth deterioration and infections. Important breakthroughs have been made in the pathophysiology of xerostomia and new treatments are developed.


Assuntos
Xerostomia/diagnóstico por imagem , Xerostomia/prevenção & controle , Acupuntura , Terapia Genética , Humanos , Cintilografia , Glândulas Salivares/transplante , Glândula Submandibular/metabolismo , Glândula Submandibular/efeitos da radiação , Xerostomia/fisiopatologia , Xerostomia/terapia
13.
Laryngorhinootologie ; 80(5): 253-6, 2001 May.
Artigo em Alemão | MEDLINE | ID: mdl-11417247

RESUMO

BACKGROUND: High-dose radioiodine therapy following total thyroidectomy is standard for patients suffering from differentiated thyroid carcinoma and contributes significantly to their favourable prognosis. Due to active iodine accumulation, high focal radiation doses are received by the salivary glands. PATIENTS/RESULT: Report on two patients, who received multiple high-dose radioiodine treatments because of a differentiated metastatic thyroid carcinoma. A few years later, they developed a mucoepidermoid carcinoma of the salivary glands. Due to the high cumulative radiation dose, radiation-induced secondary malignancies following radiation-induced sialadenitis appears likely, although no causal connection could be proven. CONCLUSION: Consistent protection of the salivary glands during radioiodine therapy as well as the follow-up of the many long-term survivors of differentiated thyroid carcinomas is desirable to further lower the salivary gland-related side effects and to detect secondary malignancies as early as possible.


Assuntos
Carcinoma Mucoepidermoide/diagnóstico , Neoplasias Induzidas por Radiação/diagnóstico , Segunda Neoplasia Primária/diagnóstico , Neoplasias Parotídeas/diagnóstico , Neoplasias da Glândula Submandibular/diagnóstico , Neoplasias da Glândula Tireoide/diagnóstico por imagem , Adulto , Carcinoma Mucoepidermoide/cirurgia , Seguimentos , Humanos , Masculino , Neoplasias Induzidas por Radiação/cirurgia , Segunda Neoplasia Primária/cirurgia , Glândula Parótida/efeitos da radiação , Glândula Parótida/cirurgia , Neoplasias Parotídeas/cirurgia , Radiografia , Radioterapia de Alta Energia , Reoperação , Glândula Submandibular/efeitos da radiação , Glândula Submandibular/cirurgia , Neoplasias da Glândula Submandibular/cirurgia
14.
Strahlenther Onkol ; 175 Suppl 4: 6-12, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10584133

RESUMO

BACKGROUND AND PURPOSE: Parenchymal impairment of salivary glands following high-dose radioiodine treatment is a well-known side effect in general caused by free radicals. Therefore, the radioprotective effect of the radical scavenger amifostine was evaluated prospectively in patients receiving high-dose radioiodine treatment. PATIENTS AND METHODS: Parenchymal function was assessed by quantitative salivary gland scintigraphy performed in 50 patients with differentiated thyroid cancer prior to and 3 months after high-dose radioiodine treatment with either 3 GBq 131I (n = 21) or 6 GBq 131I (n = 29) in a double-blinded, placebo-controlled study. Twenty-five patients treated with 500 mg/m2 amifostine intravenously prior to high-dose radioiodine treatment were compared to 25 control patients receiving physiological saline solution. Xerostomia was graded according to WHO-criteria. RESULTS: In 25 control patients high-dose radioiodine treatment significantly (p < 0.001) reduced parenchymal function of parotid and submandibular glands by 40.2 +/- 14.1% and 39.9 +/- 15.3%, respectively. Nine out of these 25 patients developed Grade I and 2 Grade II xerostomia. In contrast, in 25 amifostine-treated patients there was no significant (p = 0.691) decrease in parenchymal function following high-dose radioiodine treatment, and xerostomia did not occur in any of them. CONCLUSION: Parenchymal damage of salivary glands induced by high-dose radioiodine treatment can be significantly reduced by amifostine which may improve quality of life of patients with differentiated thyroid cancer.


Assuntos
Adenocarcinoma Folicular/radioterapia , Amifostina/farmacologia , Carcinoma Papilar/radioterapia , Radioisótopos do Iodo/uso terapêutico , Protetores contra Radiação/farmacologia , Glândulas Salivares/efeitos dos fármacos , Glândulas Salivares/efeitos da radiação , Neoplasias da Glândula Tireoide/radioterapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Método Duplo-Cego , Feminino , Humanos , Radioisótopos do Iodo/efeitos adversos , Masculino , Pessoa de Meia-Idade , Glândula Parótida/efeitos dos fármacos , Glândula Parótida/efeitos da radiação , Placebos , Estudos Prospectivos , Cintilografia , Dosagem Radioterapêutica , Glândulas Salivares/diagnóstico por imagem , Glândula Submandibular/efeitos dos fármacos , Glândula Submandibular/efeitos da radiação , Fatores de Tempo , Xerostomia/etiologia , Xerostomia/prevenção & controle
15.
Nucl Med Commun ; 17(8): 681-6, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8878127

RESUMO

This study was undertaken to quantify salivary gland parenchymal damage after radioiodine treatment with a standard protective regimen of ascorbic acid. Altogether, 106 patients underwent quantitative salivary gland scintigraphy with 99Tcm-pertechnetate prior to and 3 months after radioiodine therapy. Parenchymal function was quantified by calculating 99Tcm-pertechnetate uptake 13 min post-injection. Patients received 131I doses ranging from 400 MBq to 24 GBq (cumulative). Among the patients who received large doses of 131I, severe parenchymal destruction could be visually analysed as well as quantitatively evaluated. In contrast, after low-dose radioiodine treatment, mild parenchymal impairment was demonstrated by quantitative evaluation only. In conclusion, standardized quantitative salivary gland scintigraphy is essential for the reliable detection of mild parenchymal malfunction. Despite the standard protection regimen using ascorbic acid as a sialogogue, radioiodine therapy induces loss of salivary gland parenchymal function even with low doses of 131I.


Assuntos
Radioisótopos do Iodo/efeitos adversos , Lesões por Radiação/diagnóstico por imagem , Lesões por Radiação/etiologia , Glândulas Salivares/diagnóstico por imagem , Glândulas Salivares/lesões , Adulto , Idoso , Idoso de 80 Anos ou mais , Relação Dose-Resposta à Radiação , Feminino , Humanos , Radioisótopos do Iodo/administração & dosagem , Radioisótopos do Iodo/uso terapêutico , Masculino , Pessoa de Meia-Idade , Glândula Parótida/diagnóstico por imagem , Glândula Parótida/lesões , Glândula Parótida/efeitos da radiação , Cintilografia , Dosagem Radioterapêutica , Glândulas Salivares/efeitos da radiação , Pertecnetato Tc 99m de Sódio , Glândula Submandibular/diagnóstico por imagem , Glândula Submandibular/lesões , Glândula Submandibular/efeitos da radiação , Doenças da Glândula Tireoide/radioterapia , Neoplasias da Glândula Tireoide/radioterapia
16.
Rofo ; 125(6): 546-51, 1976 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-137852

RESUMO

Following high dose radio-iodine therapy, some radiation damage to the salivary glands is to be expected since iodine is taken up by these glands. The great individual variation in the uptake makes it impossible to predict the severity of the damage. T max and maximal excretion capacity after stimulation were therefore estimated by a camera functional scintigram with digital read out in patients following radioiodine therapy (0.1-3.2 Ci); the excretion index was used as an indirect measure of salivary flow. After a dose up to 0.3 Ci there is a change of T max and maximal excretion capacity in 30% of patients; after a dose of 0.5 to 1 Ci it is found in 60 and 80% and after very high doses of 1.1 to 3.2 Ci an abnormal Tmax was found in two-thirds of all patients and reduced or absent excretion capacity in all nine patients in this group. The excretion index also depended significantly on the cumulative dose. All patients who had received very high doses showed marked hyposialia or asialia. The early results of interim examinations suggest, similar to radio-iodine induced hypothyroidism, a cumulative risk of reduced function. In view of the long survival period of patients with differentiated thyroid carcinomas attention should be drawn to this side effect.


Assuntos
Radioisótopos do Iodo/efeitos adversos , Iodo/metabolismo , Glândulas Salivares/metabolismo , Relação Dose-Resposta a Droga , Relação Dose-Resposta à Radiação , Humanos , Radioisótopos do Iodo/uso terapêutico , Glândula Parótida/efeitos da radiação , Doses de Radiação , Lesões por Radiação/metabolismo , Cintilografia , Glândulas Salivares/efeitos da radiação , Salivação/efeitos da radiação , Glândula Sublingual/efeitos da radiação , Glândula Submandibular/efeitos da radiação , Neoplasias da Glândula Tireoide/radioterapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA